RT Journal Article
SR Electronic
T1 Joint estimation and imputation of variant functional effects using high throughput assay data
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.01.06.23284280
DO 10.1101/2023.01.06.23284280
A1 Yu, Tian
A1 Fife, James D.
A1 Adzhubey, Ivan
A1 Sherwood, Richard
A1 Cassa, Christopher A.
YR 2023
UL http://medrxiv.org/content/early/2023/01/07/2023.01.06.23284280.abstract
AB Deep mutational scanning assays enable the functional assessment of variants in high throughput. Phenotypic measurements from these assays are broadly concordant with clinical outcomes but are prone to noise at the individual variant level. We develop a framework to exploit related measurements within and across experimental assays to jointly estimate variant impact. Drawing from a large corpus of deep mutational scanning data, we collectively estimate the mean functional effect per AA residue position within each gene, normalize observed functional effects by substitution type, and make estimates for individual allelic variants with a pipeline called FUSE (Functional Substitution Estimation). FUSE improves the correlation of functional screening datasets covering the same variants, better separates estimated functional impacts for known pathogenic and benign variants (ClinVar BRCA1, p=2.24×10−51), and increases the number of variants for which predictions can be made (2,741 to 10,347) by inferring additional variant effects for substitutions not experimentally screened. For UK Biobank patients who carry a rare variant in TP53, FUSE significantly improves the separation of patients who develop cancer syndromes from those without cancer (p=1.77×10−6). These approaches promise to improve estimates of variant impact and broaden the utility of screening data generated from functional assays.HighlightsUses functional assay data collectively to improve the estimation of allelic variant effectsInfers the impact of variants not experimentally screened, broadening the utility of assaysImproves the discrimination of clinically actionable variants within ClinVarSignificantly separates patients at risk for cancer syndromes in the UK BiobankCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the National Human Genome Research Institute (R01HG010372).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced are available online at: figshare.com/articles/dataset/FUSE_estimated_score_figshare_xlsx/21644711 https://static-content.springer.com/esm/art%3A10.1038%2Fs41467-022-28884-7/MediaObjects/41467_2022_28884_MOESM9_ESM.xlsx https://static-content.springer.com/esm/art%3A10.1038%2Fs41467-022-28884-7/MediaObjects/41467_2022_28884_MOESM10_ESM.xlsx https://www.cell.com/cms/10.1016/j.cell.2021.01.041/attachment/6d9a15e7-fa20-4305-8054-99735cb3cd15/mmc6.xlsx https://figshare.com/articles/dataset/Raw_variant_effect_predictions_and_DMS_data_for_benchmarking_variant_effect_predictors_/12369359/1 https://elifesciences.org/download/aHR0cHM6Ly9jZG4uZWxpZmVzY2llbmNlcy5vcmcvYXJ0aWNsZXMvNTgwMjYvZWxpZmUtNTgwMjYtc3VwcDYtdjEuY3N2/elife-58026-supp6-v1.csv?_hash=K9Cej66q0D8H2rZuLN3Hm6VpMVjMsa7clkQm015qZEI%3D https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181777/bin/NIHMS1501643-supplement-2.xlsx https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168352/bin/NIHMS1501645-supplement-5.xlsx https://static-content.springer.com/esm/art%3A10.1038%2Fs41588-018-0122-z/MediaObjects/41588_2018_122_MOESM3_ESM.txt https://static-content.springer.com/esm/art%3A10.1038%2Fs41588-018-0122-z/MediaObjects/41588_2018_122_MOESM4_ESM.txt https://www.pnas.org/doi/suppl/10.1073/pnas.1915680117/suppl_file/pnas.1915680117.sd01.xlsx